Page 2 - Khiron Academy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Khiron academy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Khiron Academy Today - Breaking & Trending Today

Khiron Life Sciences Reports First Quarter 2021 Financial Results

Record revenues of $2.8 million in Q1 2021, a 49% increase from the prior year and 13% increase from Q4 2020 Record gross profits (before fair market value. ....

United States , United Kingdom , Elsa Navarro , Paola Ricardo , Khiron Europe , Alvaro Torres , Joel Friedman , Tejinder Virk , Chris Naprawa , International Financial Reporting Standards , Health Service , Khiron Academy , Health Services , Colombia Cancer League , Khiron Life Sciences Corp , Regulation Services Provider , Medical Cannabis Product , Khiron Life Sciences , Latin America , Key Financial , Medical Cannabis , Continuing Professional Development , Three Months Ending March , Chief Executive Officer , Cellen Therapeutics , Project Twenty ,

Khiron Life Sciences : Reports First Quarter 2021 Financial Results

Record revenues of $2.8 million in Q1 2021, a 49% increase from the prior year and 13% increase from Q4 2020 Record gross profits of $1.1 million, a 171% improvement over Q4 2020 and record. | May 27, 2021 ....

United States , United Kingdom , Elsa Navarro , Paola Ricardo , Khiron Europe , Alvaro Torres , Joel Friedman , Tejinder Virk , Chris Naprawa , International Financial Reporting Standards , Health Service , Khiron Academy , Health Services , Colombia Cancer League , Khiron Life Sciences Corp , Regulation Services Provider , Medical Cannabis Product , Khiron Life Sciences , Latin America , Key Financial , Medical Cannabis , Continuing Professional Development , Three Months Ending March , Chief Executive Officer , Cellen Therapeutics , Project Twenty ,

Khiron Life Sciences Reports First Quarter 2021 Financial Results

Khiron Life Sciences Reports First Quarter 2021 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Elsa Navarro , Paola Ricardo , Khiron Europe , Alvaro Torres , Joel Friedman , Tejinder Virk , Chris Naprawa , International Financial Reporting Standards , Health Service , Khiron Academy , Health Services , Colombia Cancer League , Khiron Life Sciences Corp , Regulation Services Provider , Medical Cannabis Product , Khiron Life Sciences , Latin America , Key Financial , Medical Cannabis , Continuing Professional Development , Three Months Ending March , Chief Executive Officer , Cellen Therapeutics , Project Twenty ,

Project Twenty 21 Releases Findings: Cannabis Dramatically Improves Lives Of Patients With Debilitating Conditions

Psychopharmacology.
The project, poised to provide patients access to affordable medical cannabis treatment, was launched in 2019 at the Royal College of Psychiatrists in London.
The UK s national medical cannabis registry is monitored by an independent scientific body, Drug Science.
Vertically integrated CPG cannabis company
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) was the first supplier of EU-GMP high-THC dried cannabis flower to Project Twenty 21 s findings. Khiron, which has core operations in Latin America, is a founding member of Project Twenty 21.
Project Twenty 21 s Findings
The findings suggest that patients living with chronic pain, multiple sclerosis, Tourette s syndrome, epilepsy and post-traumatic stress disorder could significantly improve their quality of life by using legally prescribed cannabis. ....

United States , United Kingdom , City Of , David Nutt , Tejinder Virk , Royal College Of Psychiatrists , Khiron Academy , Khiron Life Sciences Corp , Project Twenty , Royal College , Khiron Life Sciences , Latin America , Drug Science , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , டேவிட் நட் , தேஜீந்தர் கன்னி , அரச கல்லூரி ஆஃப் மனநல மருத்துவர்கள் , கிறோன் வாழ்க்கை அறிவியல் கார்ப் , ப்ராஜெக்ட் இருபது , அரச கல்லூரி , கிறோன் வாழ்க்கை அறிவியல் , லத்தீன் அமெரிக்கா , மருந்து அறிவியல் ,

Khiron Comments on the Results of Project Twenty21 - UK's Largest Observational Study into Medical Cannabis Products

(1)
Khiron is a founding member of Project Twenty 21 and was the first supplier of EU-GMP high-THC dried cannabis flower to the study
The findings show that medical Cannabis dramatically improves quality of life for people with life-limiting conditions, including Chronic Pain, Multiple Sclerosis, Tourette s Syndrome and PTSD
Legal prescriptions allow patients to access medical cannabis without engaging in criminality and to avoid dependency associated with other medicines commonly prescribed for these debilitating conditions
TORONTO, May 11, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal Psychopharmacology of the first findings arising from Project Twenty 21, UK s first and largest national medical cannabis registry that was launch ....

United Kingdom , United States , City Of , Paola Ricardo , Khiron Europe , David Nutt , Alvaro Torres , Tejinder Virk , Cannabis Clinicians Society , Khiron Academy , Europe Communications , National Institute For Clinical Excellence , Prnewswire Khiron Life Sciences Corp , Khiron Life Sciences Corp , Regulation Services Provider , Royal College Of Psychiatrists , Project Twenty , Chronic Pain , Multiple Sclerosis , Life Sciences , Latin America , Royal College , Drug Science , Post Traumatic Stress Disorder , Project Twety , National Institute ,